In the case of CKD, the incidence of fractures [2], morbidity, and mortality are higher than in the general population [3], even among patients with adequate control of calcium, phosphate, and parathyroid hormone (PTH) levels with calcimimetics [4,5]. Here, PTH is linked to chronic kidney disease.